ASB3 expression aggravates inflammatory bowel disease by targeting TRAF6 protein stability and affecting the intestinal microbiota
M.-y. Cheng, B. Xu, Y. Sun, J. Wang, Y. Lu, C. Shi, T. Pan, W. Zhao, X. Li, X. Song, J. Wang, N. Wang, W. Yang, Y. Jiang, H. Huang, , X. Cao
This study shows ASB3 worsens inflammatory bowel disease by destabilizing TRAF6 and altering gut microbiota, suggesting ASB3 inhibition could be a therapeutic strategy.
mBio · Sep 11, 2024Peer-reviewedImmunology